MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Melatonin Modulates NLRP3 Inflammasome Activation through TLR2 to Protect Against Parkinson’s Disease

    XY. Wang, JW. Li, HS. Liu, XN. Xiong (Wuhan, China)

    Objective: This study aims to investigate the impact of MLT on inflammation signaling pathway mediated by TLR2 in α-synuclein (α-syn) overexpressed BV2 cells and PD…
  • 2024 International Congress

    Insulin-like growth factor 2 and inflammatory response in Parkinson Disease: Potential predictor marker

    CA. Aguilera, FG. Grünenwald, VU. Urbina, EL. Larraechea, RLV. Vidal (Santiago, Chile)

    Objective: Clinical diagnosis Parkinson's disease (PD), is often difficult, with the appearance of motor symptoms hence the importance of identify non-invasive early markers is a…
  • 2024 International Congress

    Hippocampal volume in Parkinson’s Disease in south India

    R. Kandadai, T. Syed, A. Arora, T. Sd, S. Kola, S. Yaranagula, V. Prasad, R. Alugolu, S. Turaga, R. Borgohain (Hyderabad, India)

    Objective: To analyse hippocampal volume differences among the patients with Parkinson’s disease and healthy individuals. Background: In humans, hippocampus is involved in regulation of emotions,…
  • 2024 International Congress

    MIBG Uptake in the Major Salivary Glands in Patients with Parkinson’s Disease and Dementia with Lewy Bodies

    J. Ebina, S. Mizumura, H. Morioka, M. Shibukawa, J. Nagasawa, M. Yanagihashi, T. Hirayama, N. Ishii, Y. Kobayashi, A. Inaba, S. Orimo, O. Kano (Tokyo, Japan)

    Objective: The aim of the study was to compare the metaiodobenzylguanidine (MIBG) uptake in the major salivary glands (MSG) in patients with Parkinson’s disease (PD)…
  • 2024 International Congress

    Investigating the Use of 18F-DOPA PET/CT to Improve Diagnosis and Clinical Management of Parkinson’s Disease in South Australian Movement Disorder Clinics.

    D. Sharma, M. Nottage, W. Vallat, R. Wilcox, M. Tan, N. Liam, A. Dwyer (Adelaide, Australia)

    Objective: Evaluate the impact of 18F-DOPA PET/CT on clinical management for Parkinsonism. Background: Parkinson’s Disease affects >100,000 people in Australia with an economic burden of…
  • 2024 International Congress

    Functional Connectivity Changes Associated with Interlimb Coordination Force Deficits in Parkinson’s Disease

    A. Bower, J. Chung, R. Burciu (Newark, USA)

    Objective: To investigate differences in the functional connectivity of motor regions between individuals with and without Parkinson’s disease (PD) during a force task requiring coordination…
  • 2024 International Congress

    Assessment of Visual Field in Patients with Moderate-to-Severe Parkinson’s Disease

    S. Mehta, M. Syed, S. Naghizadehkashani, K. Shivok, L. Krisa, C. Matias, C. Wu, T. Liang, R. Sergott, M. Alizadeh (Philadelphia, USA)

    Objective: Utilization of visual field testing and diffusion tensor imaging (DTI) to assess visual field deficits in patients with moderate-to-severe Parkinson’s Disease (PD) and identify…
  • 2024 International Congress

    Predictive elements for unilateral prelemniscal radiations radiofrequency lesions: A novel surgical approach for alleviating motor symptoms in Parkinson’s disease

    A. Armas-Salazar, J. Navarro-Olvera, F. Velasco-Campos, F. Jimenez-Ponce, G. Aguado-Carrillo, J. Beltran, J. Carrillo-Ruiz (Mexico City, Mexico)

    Objective: A cohort of individuals diagnosed with Parkinson's disease (PD) underwent treatment with unilateral prelemniscal radiation radiofrequency lesions (U-Raprl). This research seeks to assess prognostic…
  • 2024 International Congress

    Cluster Analysis of Stimulation-Induced Dysarthria Subtypes in People with Parkinson’s Disease and Subthalamic Deep Brain Stimulation

    H. Jergas, JN. Petry-Schmelzer, JH. Hannemann, T. Thies, I. Rubi-Fessen, J. Quinting, V. Visser-Vandewalle, T. Tsuboi, MT. Barbe (Cologne, Germany)

    Objective: To establish different clusters with distinctive speech characteristics in people with Parkinson’s disease (PwPD) who experience stimulation-induced dysarthria (SID). Background: To date, the effect…
  • 2024 International Congress

    Longevity of Motor Benefit Achieved with Deep Brain Stimulation (DBS) of the Subthalamic Nucleus (STN) in a Single Center Cohort at the Decade Mark Post-Implantation.

    D. Caputo, R. Dipaola, S. Danish, E. Hargreaves (Neptune, USA)

    Objective: To track the degree and longevity of motor benefit achieved with STN DBS at our center. Background: Caputo et al., (2017)[1]  presented data from…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #22901 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley